For a 19‑year‑old with type 1 diabetes, weight 86 kg, creatinine 0.74 mg/dL, GFR > 90 mL/min, bicarbonate 17 mmol/L, anion gap 13, currently on metformin 750 mg daily and insulin glargine (Lantus) 15 U at 8 am and 35 U at 8 pm with carbohydrate‑to‑insulin ratios of 1 U per 6 g carbs at breakfast and 1 U per 7 g carbs at lunch/dinner and an insulin‑sensitivity factor of 25 mg/dL per U, and blood glucose values of 184 mg/dL (8 am), 220 mg/dL (noon), 262 mg/dL (5 pm), 237 mg/dL (10 pm), and 97 mg/dL (4 am), what should the morning and evening Lantus doses be and what should the insulin‑sensitivity factor and insulin‑to‑carbohydrate ratios be adjusted to?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 15, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Insulin Dose Adjustments for Type 1 Diabetes

Discontinue metformin immediately—it is not indicated for type 1 diabetes and poses unnecessary risk of lactic acidosis, particularly given the low bicarbonate (17 mmol/L) and anion gap (13) suggesting early metabolic acidosis 1, 2, 3.

Critical Context

This 19-year-old has type 1 diabetes with suboptimal control (all glucose readings elevated except the 4 AM value of 97 mg/dL) and is inappropriately on metformin. The blood glucose pattern shows:

  • Morning hyperglycemia (184 mg/dL at 8 AM)
  • Progressive daytime rise (220→262 mg/dL)
  • Evening elevation (237 mg/dL at 10 PM)
  • Appropriate overnight nadir (97 mg/dL at 4 AM)

The low bicarbonate (17 mmol/L) with anion gap of 13 raises concern for chronic metabolic acidosis, potentially exacerbated by metformin in the setting of type 1 diabetes.

Basal Insulin (Lantus) Adjustments

AM Lantus Dose

Increase from 15 units to 20 units (approximately 33% increase). The 8 AM glucose of 184 mg/dL indicates insufficient basal coverage during the overnight-to-morning period. The 4 AM glucose of 97 mg/dL is appropriate, but the rise to 184 mg/dL by 8 AM suggests dawn phenomenon requiring more morning basal insulin 1.

PM Lantus Dose

Maintain 35 units or consider slight reduction to 32 units (approximately 10% decrease). The 4 AM glucose of 97 mg/dL indicates the evening dose is providing adequate overnight coverage. The progressive daytime hyperglycemia (220→262 mg/dL) is primarily a prandial insulin issue, not a basal problem. Given the patient's weight (86 kg) and the risk of nocturnal hypoglycemia, a modest reduction may be prudent 4, 5.

Total daily basal insulin would be approximately 52 units (0.6 units/kg/day), which is appropriate for this patient's weight and represents roughly 50% of total daily insulin dose 5, 6.

Insulin-to-Carbohydrate Ratios (ICR)

Breakfast ICR

Change from 1:6 to 1:5 (more aggressive). The rise from 184 mg/dL (8 AM) to 220 mg/dL (noon) indicates insufficient breakfast bolus coverage. This represents a 20% increase in insulin per gram of carbohydrate 6.

Lunch ICR

Change from 1:7 to 1:5 (more aggressive). The dramatic rise from 220 mg/dL (noon) to 262 mg/dL (5 PM) indicates grossly inadequate lunch coverage. This represents a 40% increase in insulin per gram of carbohydrate 6.

Dinner ICR

Change from 1:7 to 1:6 (moderately more aggressive). The modest decline from 262 mg/dL (5 PM) to 237 mg/dL (10 PM) suggests dinner coverage is closer to adequate but still insufficient. This represents a 17% increase 6.

Insulin Sensitivity Factor (ISF)

Change from 25 mg/dL per unit to 20 mg/dL per unit (more aggressive correction). Using the 1800 rule: 1800 ÷ estimated total daily dose of ~100 units = 18 mg/dL per unit. However, starting at 20 mg/dL per unit is safer to avoid overcorrection. The current ISF of 25 is too conservative given persistent hyperglycemia throughout the day 6, 5.

Monitoring and Safety Considerations

Critical pitfall: The low bicarbonate (17 mmol/L) requires immediate evaluation for diabetic ketoacidosis risk, especially after stopping metformin. Check beta-hydroxybutyrate and ensure adequate insulin coverage during the transition 7, 3, 8.

Hypoglycemia prevention: The 4 AM glucose of 97 mg/dL is appropriate, but with increased insulin doses, monitor for overnight hypoglycemia. Consider continuous glucose monitoring if not already in place 5, 9.

Titration approach: Implement these changes gradually over 3-5 days, adjusting one parameter at a time if possible. Start with basal insulin adjustments, then modify ICRs, then fine-tune ISF 4.

Expected total daily insulin: With these adjustments, total daily insulin should approximate 0.8-1.0 units/kg/day (69-86 units/day for 86 kg), which is typical for adolescents with type 1 diabetes 6, 10.

References

Guideline

american association of clinical endocrinology clinical practice guideline: developing a diabetes mellitus comprehensive care plan-2022 update.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologist, 2022

Related Questions

For a patient with type 1 diabetes currently on insulin glargine (Lantus) 18 U daily, daytime insulin‑sensitivity factor of 25 mg/dL per unit, overnight factor of 50 mg/dL per unit, and insulin‑to‑carbohydrate ratio of 1 U per 8 g, who ate 56 g carbohydrate at 14:00 with a blood glucose of 200 mg/dL at 16:00, then ate 82 g carbohydrate at 19:00 with a blood glucose of 199 mg/dL at 22:00, and had a blood glucose of 132 mg/dL at 04:00, what should the insulin glargine dose, insulin‑sensitivity factor, and insulin‑to‑carbohydrate ratio be adjusted to?
In a 51-year-old woman with recent left superior cerebellar infarct, normal renal function, weight 49.3 kg, currently on metformin 500 mg daily and basal insulin glargine (Lantus) 25 U with an insulin‑to‑carbohydrate ratio of 1 U per 12 g carbohydrate and an insulin sensitivity factor of 35 mg/dL per unit, and post‑prandial glucose values >200 mg/dL, what should the basal insulin dose, insulin‑to‑carbohydrate ratio, and insulin sensitivity factor be, and are any additional oral diabetes medications recommended?
For a 19‑year‑old patient with type 1 diabetes weighing 86.2 kg who is currently taking insulin glargine (Lantus) 12 U at 08:00 and 35 U at 20:00 and uses insulin‑to‑carbohydrate ratios of 1 U per 5 g carbs for breakfast and lunch and 1 U per 6 g carbs for dinner, what should the basal Lantus dose and insulin‑to‑carbohydrate ratio be adjusted to?
For a 46‑year‑old male with type 3c diabetes, weight 88 kg, impaired renal function, currently taking 10 units of Lantus (insulin glargine) daily with an insulin sensitivity factor of 50 mg/dL per unit and an insulin‑to‑carbohydrate ratio of 10 g per unit, and having blood glucose readings of 263 mg/dL at 5 pm and 231 mg/dL at 2 am after meals of 80 g, 82 g, and 34 g carbohydrate, what should his Lantus dose, insulin sensitivity factor, and insulin‑to‑carbohydrate ratio be?
A 46-year-old woman with a current hemoglobin A1c of 6.2% (previously 11.6% nine months ago) has fasting glucose around 150 mg/dL; should she continue taking 15 units of insulin glargine (Lantus) at bedtime and 7 units of insulin lispro with each meal?
Can fetal paracentesis be performed, and at what gestational age is it appropriate?
What is the equivalent dose of diazepam for 1 mg of clonazepam?
What is the appropriate prazosin dosing regimen for a teenager, including starting dose, titration schedule, maximum dose, and considerations for treating nightmares or hypertension?
Should I order a gene expression profiling assay for a carcinoma of unknown primary?
What are the clinical applications of InBody bioelectrical impedance testing in adult patients?
Can a 4-year-old child with a solitary kidney be given paracetamol?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.